Calcium and vitamin D metabolism in sarcoidosis

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 30, Issue 2, 2013, Pages 113-120

  Baughman, Robert P ^a   Janovcik, J ^b   Ray, M ^a   Sweiss, N ^c   Lower, E E ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALGARY   (Canada)

^c UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Calcium; Hypercalcemia; Hyperparathyroidism; Renal failure; Vitamin D

Indexed keywords

AZATHIOPRINE; CALCIDIOL 1 MONOOXYGENASE; CALCIUM; COLECALCIFEROL; CREATININE; CYCLOPHOSPHAMIDE; HYDROXYCHLOROQUINE; INFLIXIMAB; LEFLUNOMIDE; METHOTREXATE; PREDNISONE; VITAMIN D; CALCIUM INTAKE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CLINICAL FEATURE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; HUMAN; HYPERCALCEMIA; KIDNEY FAILURE; LUNG SARCOIDOSIS; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; REPRODUCIBILITY; VITAMIN BLOOD LEVEL; VITAMIN D METABOLISM; VITAMIN SUPPLEMENTATION; BLOOD; CALCIUM INTAKE; SARCOIDOSIS;

CALCIUM; CALCIUM, DIETARY; HUMANS; HYPERCALCEMIA; SARCOIDOSIS; VITAMIN D;

EID: 84885104488     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Hunninghake GW, Costabel U, Ando M, et al. ATS/ERS/WASOG statement on sarcoidosis. American Thoracic Society/European Respiratory Society/World Association of Sarcoidosis and other Granulomatous Disorders. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 149-73.
2. Baughman RP, Teirstein AS, Judson MA, et al. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164: 1885-9. (Pubitemid 33152325)
3. Morimoto T, Azuma A, Abe S, et al. Epidemiology of sarcoidosis in Japan. Eur Respir J 2008; 31: 372-9.
4. Kim DS. Sarcoidosis in Korea: report of the Second Nationwide Survey. Sarcoidosis Vasc Diffuse Lung Dis 2001; 18: 176-80.
5. Ponce C, Gujral JS. Renal failure and hypercalcemia as initial manifestations of extrapulmonary sarcoidosis. South Med J 2004; 97: 590-2. (Pubitemid 38802776)
6. Rikitake Y, Kinoshita Y, Kotani Y, et al. Sarcoidosis with hypercalcemia-successful treatment of renal insufficiency and renal calcification with prednisolone. Intern Med 1994; 33: 222-5. (Pubitemid 24199869)
7. Rizzato G, Fraioli P, Montemurro L. Nephrolithiasis as a presenting feature of chronic sarcoidosis. Thorax 1995; 50: 555-9.
8. Sharma OP. Hypercalcemia in granulomatous disorders: a clinical review. Curr Opin Pulm Med 2000; 6: 442-7. (Pubitemid 30637660)
9. Hamada, K., S. Nagai, T. Tsutsumi, and T. Izumi. 1998. Ionized calcium and 1,25-dihydroxyvitamin D concentration in serum of patients with sarcoidosis. Eur Respir J 11:1015-1020. (Pubitemid 28281016)
10. Mason RS, Frankel T, Chan YL, Lissner D, Solomon P. Vitamin D conversion by sarcoid lymph node homogenate. Ann Intern Med 1984; 100: 59-61. (Pubitemid 14219130)
11. Falk S, Kratzsch J, Paschke R, Koch CA. Hypercalcemia as a result of sarcoidosis with normal serum concentrations of vitamin D. Med Sci Monit 2007; 13: CS133-CS136. (Pubitemid 350106402)
12. Dawidson I, Jameson S. Sarcoidosis with hypercalcemia, reversible uremia and hyperparathyroidism. Scand J Urol Nephrol 1972; 6: 308-11.
13. Lang CC, McEwan SR, Ng AK. Co-existing hyperparathyroidism and sarcoidosis presenting with hypercalcaemia - a diagnostic challenge. Scott Med J 1989; 34: 503-4. (Pubitemid 19243262)
14. de Nijs RN, Jacobs JW, Algra A, Lems WF, Bijlsma JW. Prevention and treatment of glucocorticoid-induced osteoporosis with active vitamin D3 analogues: a review with meta-analysis of randomized controlled trials including organ transplantation studies. Osteoporos Int 2004; 15: 589-602. (Pubitemid 39121106)
15. Wejse C, Gomes VF, Rabna P, et al. Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial. Am J Respir Crit Care Med 2009; 179: 843-50.
16. Martineau AR, Timms PM, Bothamley GH, et al. High-dose vitamin D(3) during intensive-phase antimicrobial treatment of pulmonary tuberculosis: a double-blind randomised controlled trial. Lancet 2011; 377: 242-50.
17. Sweiss NJ, Lower EE, Korsten P, Niewold TB, Favus MJ, Baughman RP. Bone Health Issues in Sarcoidosis. Curr Rheumatol Rep 2011.
18. Burke RR, Rybicki BA, Rao DS. Calcium and vitamin D in sarcoidosis: how to assess and manage. Semin.Respir Crit Care Med 2010; 31: 474-84.
19. Kavathia D, Buckley JD, Rao D, Rybicki B, Burke R. Elevated 1, 25-dihydroxyvitamin D levels are associated with protracted treatment in sarcoidosis. Respir Med 2010; 104: 564-70.
20. Scadding JG. Prognosis of intrathoracic sarcoidosis in England. Br Med J 1961; 4: 1165-72.
21. Judson MA, Baughman RP, Teirstein AS, Terrin ML, Yeager H Jr, and the ACCESS Research group.Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16: 75-86.
22. Goldstein RA, Israel HL, Becker KL, Moore CF. The infrequency of hypercalcemia in sarcoidosis. Am J Med 1971; 51: 21-30.
23. Pietinalho A, Ohmichi M, Hiraga Y, Lofroos AB, Selroos O. The mode of presentation of sarcoidosis in Finland and Hokkaido, Japan. A comparative analysis of 571 Finnish and 686 Japanese patients. Sarcoidosis 1996; 13: 159-66. (Pubitemid 26332094)
24. Gillman A, Steinfort C. Sarcoidosis in Australia. Intern Med J 2007; 37: 356-9. (Pubitemid 47029889)
25. Diamond TH, Wing J, Hirschowitz SL, Botha JR. Hypercalcaemia in sarcoidosis co-existing with primary hyperparathyroidism. A case report. S Afr J Surg 1989; 27: 26-28. (Pubitemid 19139646)
26. Robinson RG, Kerwin DM, Tsou E. Parathyroid adenoma with coexistent sarcoid granulomas. A hypercalcemic patient. Arch Intern Med 1980; 140: 1547-8. (Pubitemid 10024979)
27. Yu N, Leese GP, Smith D, Donnan P T. The natural history of treated and untreated primary hyperparathyroidism: the parathyroid epidemiology and audit research study. QJM 2011; 104: 513-21.
28. Siilin H, Lundgren E, Mallmin H, et al. Prevalence of primary hyperparathyroidism and impact on bone mineral density in elderly men: MrOs Sweden. World J Surg 2011; 35: 1266-72.
29. Yu N, Donnan PT, Murphy MJ, Leese GP. Epidemiology of primary hyperparathyroidism in Tayside, Scotland, UK. Clin Endocrinol (Oxf) 2009; 71: 485-93.
30. Adams JS, Diz MM, Sharma OP. Effective reduction in the serum 1,25-dihydroxyvitamin D and calcium concentration in sarcoidosis-associated hypercalcemia with short-course chloroquine therapy. Ann Intern Med 1989; 111: 437-8. (Pubitemid 19231297)
31. Vucinic V, Skodric-Trifunovic V, Ignjatovic S. How to diagnose and manage difficult problems of calcium metabolism in sarcoidosis: an evidence-based review. Curr Opin Pulm Med 2011; 17: 297-302.
32. Baughman RP, Nunes H. Therapy for sarcoidosis: evidence-based recommendations. Expert Rev Clin Immunol 2012; 8: 95-103.
33. Adams JS, Sharma OP, Diz M. Ketoconazole decreases the serum 1,25 dihydroxyvitamin D and calcium concentration in sarcoidosis associated hypercalcemia. J Clin Endocrinol Metab 1990; 70: 1090-5.
34. Gibbs C J, Peacock M. Hypercalcaemia due to sarcoidosis corrects with bisphosphonate treatment. Postgrad Med J 1986; 62: 937-8. (Pubitemid 17176550)
35. Sinha RN, Fraser WD, Casson IF. Long-term management of hypercalcaemia in chronically active sarcoidosis. J R Soc Med 1997; 90: 156-7. (Pubitemid 27135949)
36. Schutt AC, Bullington WM, Judson MA. Pharmacotherapy for pulmonary sarcoidosis: a Delphi consensus study. Respir Med 2010; 104: 717-23.
37. Mahevas M, Lescure FX, Boffa JJ, et al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47 patients. Medicine (Baltimore) 2009; 88: 98-106.
38. Moyses-Neto M, Guimaraes FM, Ayoub FH, Vieira-Neto OM, Costa JA, Dantas M. Acute renal failure and hypercalcemia. Ren Fail 2006; 28: 153-9.
39. Marcus JF, Shalev SM, Harris CA, Goodin DS, Josephson SA. Severe hypercalcemia following vitamin d supplementation in a patient with multiple sclerosis: a note of caution. Arch Neurol 2012; 69: 129-32.
40. Kaptein S, Risselada AJ, Boerma EC, Egbers PH, Nieboer P. Life-threatening complications of vitamin D intoxication due to over-thecounter supplements. Clin Toxicol (Phila) 2010; 48: 460-2.
41. Kallas M, Green F, Hewison M, White C, Kline G. Rare causes of calcitriol-mediated hypercalcemia: a case report and literature review. J Clin Endocrinol Metab 2010; 95: 3111-7.
42. Richmond BW, Drake WP. Vitamin D, innate immunity, and sarcoidosis granulomatous inflammation: insights from mycobacterial research. Curr Opin Pulm Med 2010; 16: 461-4.
43. Zhang JT, Chan C, Kwun SY, Benson KA. A Case of Severe 1,25-Dihydroxyvitamin D-Mediated Hypercalcemia due to a Granulomatous Disorder. J Clin Endocrinol Metab 2012.
44. Lavender TW, Martineau AR, Quinton R, Schwab U. Severe hypercalcaemia following vitamin D replacement for tuberculosis-associated hypovitaminosis D. Int J Tuberc Lung Dis 2012; 16: 140.
45. Frolich A, Nielsen BF, Transbol I. Respective roles of 25 hydroxy-vitamin D, PTH, phosphate and renal function for the 1-alpha-hydroxylase activity in primary hyperparathyroidism. Miner Electrolyte Metab 1990; 16: 210-5. (Pubitemid 20329933)